Overview
Two things are worth knowing before stopping, and they are frequently conflated.
Symptoms come back for most women — not for everyone, and not always at the intensity they had before, but return is the usual outcome rather than the exception. Hormone therapy treats symptoms; it does not shorten the transition underneath.
And the loss of the non-symptom benefits happens too. Bone protection in particular is not retained after stopping, and bone loss resumes.
| What tends to happen | |
|---|---|
| Hot flashes and night sweats | Return in a majority of women, often within weeks |
| Sleep | Frequently worsens alongside the sweats |
| Mood and irritability | May unsettle for a period |
| Vaginal and urinary symptoms | Return, and continue to progress. These do not settle with time |
| Bone density | Protection is not retained. Loss resumes after stopping |
| Timing | Weeks to a few months. Varies widely |
The most useful distinction on this page: returning symptoms are not withdrawal. They are the symptoms that were being treated, becoming apparent again. That matters because "withdrawal" implies something that passes on its own, and vasomotor symptoms may persist for years — they are not a transient effect of stopping.
Reducing gradually versus stopping abruptly
This comes up constantly and the honest answer is more nuanced than either camp suggests.
What is generally observed: stopping gradually tends to make the return of symptoms less abrupt, which many women find more manageable. Stopping suddenly is more likely to produce a noticeable rebound in the first weeks.
What is less clear: whether a gradual reduction changes the eventual outcome. The evidence that a gradual reduction reduces the likelihood of symptoms returning, as opposed to smoothing the experience of it, is limited — several studies have found similar rates of symptom return either way at longer follow-up.
So the reasonable summary is that a gradual reduction is often more comfortable and is not established to change where you end up. How to do it is a clinical decision and we do not publish schedules — that comes from your prescriber, and it depends on what you are taking, why, and how long you have been on it.
What is not sensible is stopping on your own without telling anyone, particularly if you have a uterus and are on a combined regimen, because there are things worth checking on the way out.
What needs checking when you stop
Three things, and the first is the important one.
Any bleeding. If you have a uterus, a withdrawal bleed after stopping a regimen may be expected — but bleeding that continues, restarts later, or is heavy is not something to wait out. Abnormal bleeding is the main presenting symptom of endometrial cancer, and it is highly treatable when found early. What is expected and what is not.
Bone. If bone density was part of why you were treated, stopping means that protection ends. Whether a bone density assessment or an alternative treatment is appropriate is worth discussing rather than assuming.
Cardiovascular risk, which continues to change through this period regardless of treatment. Blood pressure, lipids and glucose are worth having a current picture of. What changes through this window.
Vaginal and urinary symptoms are a separate case
Worth separating clearly, because women stop systemic treatment and are surprised by what happens here.
Hot flashes tend to improve over years, so a woman who stops after a long period may find vasomotor symptoms milder than they were.
Genitourinary symptoms do not follow that pattern. The tissue changes of menopause are progressive without treatment, so dryness, discomfort with sex and urinary symptoms return and continue to worsen.
The practical point: stopping systemic hormone therapy does not require stopping local vaginal estrogen. They are different treatments with different absorption profiles, and many women stop the first and continue the second. That is a common and appropriate arrangement, and it is frequently not offered. What local treatment does.
Why women stop, and whether the reason still holds
Worth revisiting, because some of the common reasons are based on guidance that has moved.
"I have been on it five years." Arbitrary duration limits are not supported by current guidance. Continuation is a periodic review of ongoing benefit against changing risk, not a countdown. More on that.
"I have turned 60." Also not an automatic stop. Starting after 60 and continuing past 60 are different questions.
Concern about breast cancer risk. A real consideration and one worth discussing with accurate figures rather than headline impressions — risk varies by regimen, by duration and by what else is in your picture. Why the progestogen matters.
Side effects. Frequently addressable by changing route or formulation rather than stopping entirely.
It stopped being needed. A legitimate and common reason, and the review is what establishes it.
None of these is a bad reason to have the conversation. Several are reasons to have it rather than simply to stop.
If symptoms return and are difficult
Restarting is possible and is a normal thing to do — women stop, find the symptoms unmanageable, and resume. That is not a failure of judgment.
There are also non-hormonal prescription options for vasomotor symptoms with genuine evidence behind them, which are worth knowing about particularly for women who cannot or prefer not to resume.
Cognitive behavioral therapy has good evidence for reducing how much vasomotor symptoms interfere with daily life.
And the modifiable contributors — alcohol, smoking, a cooler bedroom, weight — matter more when treatment is not doing the work. What helps with night sweats.
Frequently asked questions
Will my symptoms come back if I stop HRT? For most women, yes, though not always at the previous intensity. Hormone therapy treats symptoms rather than shortening the transition underneath.
Should I reduce gradually or stop suddenly? A gradual reduction is often more comfortable and is not clearly established to change the eventual outcome. How to do it is a decision for your prescriber.
How long before symptoms return? Weeks to a few months, varying widely between women.
Is this withdrawal? No. It is the return of symptoms that were being treated, which is different from a withdrawal effect that passes on its own.
Do I have to stop my vaginal estrogen too? No. Local vaginal estrogen is a separate treatment with minimal systemic absorption, and continuing it while stopping systemic therapy is a common arrangement.
Where this fits in your plan
Stopping is a decision worth making deliberately rather than by drifting, and it is worth making with someone who can tell you what to expect and what to watch for.
That means a conversation about why you are stopping, whether that reason still holds, what happens to bone, and what to do if the symptoms are unmanageable. What hormone therapy with us involves.
We measure first. Then we act.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
